vs
美国运通（AXP）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
美国运通的季度营收约是TriSalus Life Sciences, Inc.的1.4倍（$18.9M vs $13.2M），美国运通净利率更高（15.7% vs -73.9%，领先89.6%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 11.4%），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs -95.6%）
美国运通是全球知名的支付服务提供商，主营签账卡、信用卡产品及旅行相关服务，下设全球消费者服务、全球商业服务、全球商户与网络服务三大业务板块，还提供支付融资、网络服务、应付账款费用管理、旅行生活服务等多元解决方案。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
AXP vs TLSI — 直观对比
营收规模更大
AXP
是对方的1.4倍
$13.2M
营收增速更快
TLSI
高出48.4%
11.4%
净利率更高
AXP
高出89.6%
-73.9%
两年增速更快
TLSI
近两年复合增速
-95.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.9M | $13.2M |
| 净利润 | $3.0M | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | — | -24.8% |
| 净利率 | 15.7% | -73.9% |
| 营收同比 | 11.4% | 59.8% |
| 净利润同比 | 15.0% | 3.5% |
| 每股收益（稀释后） | — | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXPTLSI
| Q1 26 | $18.9M | — | ||
| Q4 25 | $10.9B | $13.2M | ||
| Q3 25 | $10.4B | $11.6M | ||
| Q2 25 | $10.3B | $11.2M | ||
| Q1 25 | $9.6B | $9.2M | ||
| Q4 24 | $10.0B | $8.3M | ||
| Q3 24 | $9.7B | $7.3M | ||
| Q2 24 | $9.8B | $7.4M |
净利润AXPTLSI
| Q1 26 | $3.0M | — | ||
| Q4 25 | $2.5B | $-9.8M | ||
| Q3 25 | $2.9B | $-10.8M | ||
| Q2 25 | $2.9B | $-8.3M | ||
| Q1 25 | $2.6B | $-10.4M | ||
| Q4 24 | $2.2B | $-10.1M | ||
| Q3 24 | $2.5B | $-2.4M | ||
| Q2 24 | $3.0B | $-4.3M |
毛利率AXPTLSI
| Q1 26 | — | — | ||
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% |
营业利润率AXPTLSI
| Q1 26 | — | — | ||
| Q4 25 | 28.2% | -24.8% | ||
| Q3 25 | 36.7% | -77.9% | ||
| Q2 25 | 34.4% | -65.4% | ||
| Q1 25 | 34.6% | -79.9% | ||
| Q4 24 | 27.7% | -91.8% | ||
| Q3 24 | 33.0% | -118.9% | ||
| Q2 24 | 38.6% | -111.0% |
净利率AXPTLSI
| Q1 26 | 15.7% | — | ||
| Q4 25 | 22.5% | -73.9% | ||
| Q3 25 | 27.9% | -93.5% | ||
| Q2 25 | 28.0% | -73.9% | ||
| Q1 25 | 26.8% | -113.2% | ||
| Q4 24 | 21.8% | -122.4% | ||
| Q3 24 | 25.8% | -32.6% | ||
| Q2 24 | 30.7% | -58.8% |
每股收益（稀释后）AXPTLSI
| Q1 26 | — | — | ||
| Q4 25 | $3.52 | $-0.22 | ||
| Q3 25 | $4.14 | $-0.96 | ||
| Q2 25 | $4.08 | $-0.27 | ||
| Q1 25 | $3.64 | $-0.39 | ||
| Q4 24 | $3.04 | $-0.38 | ||
| Q3 24 | $3.49 | $-0.12 | ||
| Q2 24 | $4.15 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $20.4M |
| 总债务越低越好 | $60.4M | — |
| 股东权益账面价值 | $34.0M | $-33.9M |
| 总资产 | $308.9M | $35.3M |
| 负债/权益比越低杠杆越低 | 1.78× | — |
8季度趋势，按日历期对齐
现金及短期投资AXPTLSI
| Q1 26 | — | — | ||
| Q4 25 | $742.0M | $20.4M | ||
| Q3 25 | $1.3B | $22.7M | ||
| Q2 25 | $197.0M | $26.5M | ||
| Q1 25 | $261.0M | $13.0M | ||
| Q4 24 | $221.0M | $8.5M | ||
| Q3 24 | $120.0M | $11.3M | ||
| Q2 24 | $188.0M | $16.5M |
总债务AXPTLSI
| Q1 26 | $60.4M | — | ||
| Q4 25 | $56.4B | — | ||
| Q3 25 | $57.8B | — | ||
| Q2 25 | $58.2B | — | ||
| Q1 25 | $51.2B | — | ||
| Q4 24 | $49.7B | — | ||
| Q3 24 | $53.5B | — | ||
| Q2 24 | $51.5B | — |
股东权益AXPTLSI
| Q1 26 | $34.0M | — | ||
| Q4 25 | $33.5B | $-33.9M | ||
| Q3 25 | $32.4B | $-26.7M | ||
| Q2 25 | $32.3B | $-19.4M | ||
| Q1 25 | $31.2B | $-34.4M | ||
| Q4 24 | $30.3B | $-25.9M | ||
| Q3 24 | $29.7B | $-20.4M | ||
| Q2 24 | $29.5B | $-25.3M |
总资产AXPTLSI
| Q1 26 | $308.9M | — | ||
| Q4 25 | $300.1B | $35.3M | ||
| Q3 25 | $297.6B | $36.5M | ||
| Q2 25 | $295.6B | $41.3M | ||
| Q1 25 | $282.2B | $28.6M | ||
| Q4 24 | $271.5B | $24.0M | ||
| Q3 24 | $271.0B | $27.5M | ||
| Q2 24 | $272.2B | $32.4M |
负债/权益比AXPTLSI
| Q1 26 | 1.78× | — | ||
| Q4 25 | 1.68× | — | ||
| Q3 25 | 1.78× | — | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 1.64× | — | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 1.80× | — | ||
| Q2 24 | 1.74× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.5M |
| 自由现金流率自由现金流/营收 | — | -19.1% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-19.1M |
8季度趋势，按日历期对齐
经营现金流AXPTLSI
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $-2.5M | ||
| Q3 25 | $6.2B | $-3.7M | ||
| Q2 25 | $4.4B | $-7.3M | ||
| Q1 25 | $4.8B | $-4.5M | ||
| Q4 24 | $5.8B | $-5.7M | ||
| Q3 24 | $-1.8B | $-10.8M | ||
| Q2 24 | $4.5B | $-13.4M |
自由现金流AXPTLSI
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | $-2.5M | ||
| Q3 25 | $5.6B | $-3.9M | ||
| Q2 25 | $3.7B | $-7.4M | ||
| Q1 25 | $4.3B | $-5.3M | ||
| Q4 24 | $5.3B | $-5.8M | ||
| Q3 24 | $-2.3B | $-11.0M | ||
| Q2 24 | $4.0B | $-13.5M |
自由现金流率AXPTLSI
| Q1 26 | — | — | ||
| Q4 25 | 21.4% | -19.1% | ||
| Q3 25 | 53.6% | -33.9% | ||
| Q2 25 | 36.3% | -66.1% | ||
| Q1 25 | 45.0% | -57.3% | ||
| Q4 24 | 53.1% | -69.7% | ||
| Q3 24 | -23.3% | -149.9% | ||
| Q2 24 | 40.4% | -183.1% |
资本支出强度AXPTLSI
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | 0.3% | ||
| Q3 25 | 6.3% | 1.9% | ||
| Q2 25 | 6.0% | 0.8% | ||
| Q1 25 | 4.5% | 8.2% | ||
| Q4 24 | 5.0% | 0.6% | ||
| Q3 24 | 4.7% | 2.3% | ||
| Q2 24 | 5.8% | 0.8% |
现金转化率AXPTLSI
| Q1 26 | — | — | ||
| Q4 25 | 1.25× | — | ||
| Q3 25 | 2.15× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | 2.66× | — | ||
| Q3 24 | -0.72× | — | ||
| Q2 24 | 1.50× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
TLSI
暂无分部数据
